Mass trial of repurposed MS drug that 'cuts number of Covid patients suffering serious illness by 80 per cent' begins at hospital in Hull | WHAT REALLY HAPPENED

Mass trial of repurposed MS drug that 'cuts number of Covid patients suffering serious illness by 80 per cent' begins at hospital in Hull

Earlier trials produced promising results with just 13 per cent of patients given it going on to need intensive care treatment compared to 22 per cent who received a placebo.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA